Formal lectures and a poster session will showcase cutting edge research in these fields.
It is now possible to determine which patients have an increased chance of one day needing life support with mechanical ventilation.
BUSM tool may lead to better identifying which plaques are considered at the highest risk for rupturing and causing a heart attack or stroke.
These findings, which appear as a “Letter” in the journal Blood, report on the largest number of patients in the world receiving high dose chemotherapy and stem cell transplantation.
Anna DePold Hohler, MD, FAAN, associate professor of Neurology, has been appointed Director of the Center for Military and Post Deployment Health at Boston University’s Medical Campus.
BU’s CTSI has been awarded a $23.4 million, four-year National Institutes of Health (NIH) renewal grant to train and support scientists in conducting cutting-edge clinical research and turning their discoveries into treatments, diagnostics, and improved public health.
Individuals who have been successfully treated by the department of Neurology will perform a concert dedicated to the physicians and hospital staff who have cared for them.
Researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer’s disease.
Eighteen BUSM students gathered together to meet – for the first time – their scholarship donors.
An otologist-neurotologist who specializes in complex ear diseases, the award is given to individuals who have distinguished themselves by bringing credit to their communities, their profession and the University.